All Stories

  1. (Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation
  2. Copper drives prion protein phase separation and modulates aggregation
  3. Nucleic acid actions on abnormal protein aggregation, phase transitions and phase separation
  4. Phase separation of the mammalian prion protein: Physiological and pathological perspectives
  5. Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
  6. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
  7. RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction
  8. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells
  9. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant
  10. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location
  11. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids
  12. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain
  13. Structural Basis for the Dissociation of Alpha-Synuclein Fibrils Triggered by Pressure Perturbation of the Hydrophobic Core
  14. Structural basis for the dissociation of α-synuclein fibrils triggered by pressure perturbation of the hydrophobic core
  15. Virtual drug screening for prion diseases: A valuable step?
  16. Mammalian prion amyloid formation in bacteria
  17. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria
  18. Biophysical Studies on BEX3, the p75NTR-Associated Cell Death Executor, Reveal a High-Order Oligomer with Partially Folded Regions
  19. Hot Topics in Biomedical Sciences
  20. New Approaches for the Selection and Evaluation of Anti-Prion Organic Compounds
  21. Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases
  22. Conformational dissection of Thermomyces lanuginosus lipase in solution
  23. The effect of temperature on protein refolding at high pressure: Enhanced green fluorescent protein as a model
  24. Pressure–temperature folding landscape in proteins involved in neurodegenerative diseases and cancer
  25. Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor
  26. A Comprehensive Study on the Activity and Deactivation of Immobilized Lecitase Ultra in Esterifications of Food Waste Streams to Monoacylglycerols
  27. An analysis of the factors that affect the dissociation of inclusion bodies and the refolding of endostatin under high pressure
  28. Insights into the Intramolecular Coupling between the N- and C-Domains of Troponin C Derived from High-Pressure, Fluorescence, Nuclear Magnetic Resonance, and Small-Angle X-ray Scattering Studies
  29. Continuous flow valorization of fatty acid waste using silica-immobilized lipases
  30. Moniliophthora perniciosa Necrosis- and Ethylene-Inducing Protein 2 (MpNep2) as a Metastable Dimer in Solution: Structural and Functional Implications
  31. Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils
  32. Nonspecific Prion Protein–Nucleic Acid Interactions Lead to Different Aggregates and Cytotoxic Species
  33. The role of RNA in mammalian prion protein conversion
  34. Allosteric function and dysfunction of the prion protein
  35. Erratum to “Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors” [Int. J. Biochem. Cell Biol. 43 (1) (2011) 60–64]
  36. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion
  37. Heparin Binding by Murine Recombinant Prion Protein Leads to Transient Aggregation and Formation of RNA-Resistant Species
  38. Hydrophilic cyclodextrin protected Pd nanoclusters: insights into their size control and host–guest behavior
  39. Synthesis and anti-prion activity evaluation of aminoquinoline analogues
  40. Subunit–subunit interactions and overall topology of the dimeric mitochondrial ATP synthase of Polytomella sp.
  41. 3D-reconstruction and overall topology of the dimeric mitochondrial ATP synthase of the colorless alga Polytomella sp
  42. Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins†
  43. PrP interactions with nucleic acids and glycosaminoglycans in function and disease
  44. The p53 Core Domain Is a Molten Globule at Low pH
  45. Effects of compressed fluids on the activity and structure of horseradish peroxidase
  46. Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STIl
  47. Cognate DNA Stabilizes the Tumor Suppressor p53 and Prevents Misfolding and Aggregation
  48. Enhanced prion protein stability coupled to DNA recognition and milieu acidification
  49. Response to Radulescu and Brenig: Infectious nucleic acids in prion disease: halfway there
  50. Prion Protein Complexed to N2a Cellular RNAs through Its N-terminal Domain Forms Aggregates and Is Toxic to Murine Neuroblastoma Cells
  51. Recognition mechanism of d- and l-tryptophan enantiomers using 2-hydroxypropyl-α- or β-cyclodextrins as chiral selectors
  52. The peculiar interaction between mammalian prion protein and RNA
  53. Intriguing nucleic-acid-binding features of mammalian prion protein
  54. Fourier Transform Infrared Spectroscopy Provides a Fingerprint for the Tetramer and for the Aggregates of Transthyretin
  55. Structural Insights into the Interaction between Prion Protein and Nucleic Acid†
  56. Microbial reduction of α-acetyl-γ-butyrolactone
  57. Protein folding and aggregation: Two sides of the same coin in the condensation of proteins revealed by pressure studies
  58. The Amino-Terminal PrP Domain Is Crucial to Modulate Prion Misfolding and Aggregation
  59. Volume and energy folding landscape of prion protein revealed by pressure
  60. The Hypothesis of the Catalytic Action of Nucleic Acid on the Conversion of Prion Protein
  61. Hydration and Packing Effects on Prion Folding and β-Sheet Conversion
  62. Modulation of Prion Protein Oligomerization, Aggregation, and β-sheet Conversion by 4,4′-Dianilino-1,1′-binaphthyl-5,5′-sulfonate (bis-ANS)
  63. Fibrillar Aggregates of the Tumor Suppressor p53 Core Domain†
  64. DNA Converts Cellular Prion Protein into the β-Sheet Conformation and Inhibits Prion Peptide Aggregation
  65. Pressure-induced formation of inactive triple-shelled rotavirus particles is associated with changes in the spike protein VP4